| | | | | | . 10 . 20 . 30 . 40 . 50 . 60 . 70 . 80 . 90 . 100 . 110 . 120 . 130 . 140 . 150 . 160 . 170 . 180 . 190 . 200 . 210 . 220 . 230 . 240 . 250 . 260 . 270 . 280 . 290 . 300 . 310 . 320 . 330 . 340 . 350 . 360 . 370 . 380 . 390 . 400 . 410 . 420 . 430 . 440 . 450 . 460 . 470 . 480 . 490 . 500 . 510 . 520 . 530 . 540 . 550 . 560 . 570 . 580 . 590 . 600 . 610 . 620 . 630 . 640 . 650 . 660 . 670 . 680 . 690 . 700 . 710 . 720 . 730 . 740 . 750 . 760 . 770 . 780 . 790 . 800 . 810 . 820 . 830 . 840 . 850 . 860 . 870 . 880 . 890 . 900 . 910 . 920 . 930 . 940 . 950 . 960 . 970 . 980 . 990 . 1000 . 1010 . 1020 . 1030 . 1040 . 1050 . 1060 . 1070 . 1080 . 1090 . 1100 . 1110 . 1120 . 1130 . 1140 . 1150 . 1160 . 1170 . 1180 . 1190 . 1200 . 1210 . 1220 . 1230 . 1240 . 1250 . 1260 . 1270 . 1280 . 1290 . 1300 . 1310 . 1320 . 1330 . 1340 . 1350 . 1360 . 1370 . 1380 . 1390 . 1400 . 1410 . 1420 . 1430 . 1440 |
# |
Score |
Template |
Links and tools | %id | First |
PLSPVAPARLRALLLPVGNIKRSRFLNLVKRLQDQNVVRLGDVSPDCRPNRNAFSPMAFPTGMIVYDLSISVPPISHLDLYPFEIFREPLVIIAIADGTELPGPPEGTGTYSQTQSNGTKPCNYPTVEGLQLLQQELNTLKDSHPKSLVQQLLVFDYAAVSKLVTGPDTVIWVPRPEAARSTTVKTVMCDITSRLLGELSGLAERIQEWPTVESPKASSWGPRRKPEVRPPVSEKLQHRMTMPAQLPGANGTFVDASDTNFQPAEHDSPTTFDEITRSIQVSNRVTSSIKASSKPGSKEHSRERMSAQGLGFVAASERSKSRVKGRLNIVMGTLFLQAGRWPDSLKELAEGATIARANSDYIWHAKALESILQCLLMLGWAGMDFRIPQICYPTADKFSKSVSQTPSLSHTELYSIGQSNPENRRVSLQNLANLLPDLANNILNLYTRAANITDEPVPQLVFSETVIRLARILATVYIRDGSLDDSALGNIVMNDSLKFVRSQERPRGTVSLRKSDIASFLFRALPASLGTDVPITDSTPILVGMASVLSSLGLDRKNAFVLQLLFSILIPGLVQARKIGAAEVGIHPAAGLSALNYSAFEMNALDAGPGNMEESIRILLALVGKIYGVPGIMICTDNRRDLSRHNSTAKSETVPEYDSVDSIVDRAFRHSVMNGFGDHTLKVEILKACINLCEALPDFQGVLQFTVDLLQTVKGTLMLLPDSYLGLPVIPLQEQVRLFNNVKRTVAAAKKLGDSNLEAEYWDDFMVRGVELVNSSDFKSPVRRSRTDFGFANVEERLEKKNPFIYSTFSKATTKRSEDLLIAEEPATFKVTLQNPFEFDVEIESLRIDGTGIPFEAAATHGLWLAPFTTQEYYISGVAATEGTLEIRGCTVKVKFCRERIFPIFKNFWKPQKEQKIKRTGLAAKEPFSERPLSWSSNASRSRLGASRKGPEPDIVLIKVIQKQPTVIIHSTSLSQSAIMLLEGETRSFDITLQNISTCPLDFISFSFEDSSTPQLQSALNNKENLPTDMYELELRLSTNPAMTWRRDKLHDYELSIAPGETATFTIDIYGKPGLDNAILKIDYANVCTSLADLPETFYCRQISLPLTVTVNAGVDVTRCDVLPFTSDFAWDNNKLQQSEDSRTSLGDKEAIKSMESSSTPRSITQFREAQFSQTFSRIGLSSFGFGHCLLLLDLRNAWPNPLTVSLFVNENISDGAKSPDDKLKHNPVGIHEIFDELQPGHISRFLLVVPRVYIENAQKPIPSLNVSNKRQFVVSANKLDYEAESSARECFWFREELLKHLRGSWKDVATGRGGVIDLRAIRLNARMVDALRIDDADVTFSLRPYTGDSSNDKTIENGIDSVSQTGHSKFTVKTNTFLTLSATIINRSSKPIHPLLRLQPSLRHTPHAIALDLSKRLAWSGMLQRALPILEPHQTTEVTLGV | Last |
1 | -389.000 | PF08626.11; C0NZX0_AJECG/5-1447; Transport protein Trs120 or TRAPPC9, TRAPP II complex subunit |
ali |
100 | 1 | PLSPVAPARLRALLLPVGNIKRSRFLNLVKRLQDQNVVRLGDVSPDCRPNRNAFSPMAFPTGMIVYDLSISVPPISHLDLYPFEIFREPLVIIAIADGTELPGPPEGTGTYSQTQSNGTKPCNYPTVEGLQLLQQELNTLKDSHPKSLVQQLLVFDYAAVSKLVTGPDTVIWVPRPEAARSTTVKTVMCDITSRLLGELSGLAERIQEWPTVESPKASSWGPRRKPEVRPPVSEKLQHRMTMPAQLPGANGTFVDASDTNFQPAEHDSPTTFDEITRSIQVSNRVTSSIKASSKPGSKEHSRERMSAQGLGFVAASERSKSRVKGRLNIVMGTLFLQAGRWPDSLKELAEGATIARANSDYIWHAKALESILQCLLMLGWAGMDFRIPQICYPTADKFSKSVSQTPSLSHTELYSIGQSNPENRRVSLQNLANLLPDLANNILNLYTRAANITDEPVPQLVFSETVIRLARILATVYIRDGSLDDSALGNIVMNDSLKFVRSQERPRGTVSLRKSDIASFLFRALPASLGTDVPITDSTPILVGMASVLSSLGLDRKNAFVLQLLFSILIPGLVQARKIGAAEVGIHPAAGLSALNYSAFEMNALDAGPGNMEESIRILLALVGKIYGVPGIMICTDNRRDLSRHNSTAKSETVPEYDSVDSIVDRAFRHSVMNGFGDHTLKVEILKACINLCEALPDFQGVLQFTVDLLQTVKGTLMLLPDSYLGLPVIPLQEQVRLFNNVKRTVAAAKKLGDSNLEAEYWDDFMVRGVELVNSSDFKSPVRRSRTDFGFANVEERLEKKNPFIYSTFSKATTKRSEDLLIAEEPATFKVTLQNPFEFDVEIESLRIDGTGIPFEAAATHGLWLAPFTTQEYYISGVAATEGTLEIRGCTVKVKFCRERIFPIFKNFWKPQKEQKIKRTGLAAKEPFSERPLSWSSNASRSRLGASRKGPEPDIVLIKVIQKQPTVIIHSTSLSQSAIMLLEGETRSFDITLQNISTCPLDFISFSFEDSSTPQLQSALNNKENLPTDMYELELRLSTNPAMTWRRDKLHDYELSIAPGETATFTIDIYGKPGLDNAILKIDYANVCTSLADLPETFYCRQISLPLTVTVNAGVDVTRCDVLPFTSDFAWDNNKLQQSEDSRTSLGDKEAIKSMESSSTPRSITQFREAQFSQTFSRIGLSSFGFGHCLLLLDLRNAWPNPLTVSLFVNENISDGAKSPDDKLKHNPVGIHEIFDELQPGHISRFLLVVPRVYIENAQKPIPSLNVSNKRQFVVSANKLDYEAESSARECFWFREELLKHLRGSWKDVATGRGGVIDLRAIRLNARMVDALRIDDADVTFSLRPYTGDSSNDKTIENGIDSVSQTGHSKFTVKTNTFLTLSATIINRSSKPIHPLLRLQPSLRHTPHAIALDLSKRLAWSGMLQRALPILEPHQTTEVTLGV |
1443 |
2 | -28.500 | PF07919.12; C4JTF4_UNCRE/662-1266; Gryzun, putative trafficking through Golgi |
ali follow.. |
11 | 21 | .................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................RSEGNVGEPLLAQLVITSTAHEAIRLSEVIVAFEGSLRPMTGTVDLAFPPGQTKAFNLTCIPREAGKVQVTSITLMI---------------------EDEMFNLTSVISSQSFKDPVWWSPGIKGAISRRIGKDRDTITCDILPKPPKVRI---LTPTLHDHYYTDEHAVLDIQIENEEDEAAESIEARLLGQSEDSAQIHWVDDPEACVQPRDSSPTSPTDDSGSLGQVKRKEIG-ALDSGGRKAISLNVTNTSVPLEYGLEISAFYHLLSDPETP------FKTVTLDLPFIRPFEA-NYELMPRVHPGPWPDFFHVDEPKLIDESEPR--------------------------------AHGLQQRWCLDCKLISFAHETLLID-KVSVAVTGIEGGLVRHIGPEIHTGNVEAAELHPEQVRESQ-------------------------FILELQRLTLGDRQTTT--------LNLALEVKWRRQDAEAPSSSAVELFIPTTTLVPRFVIPMGEPRVLATVTR------------------------ASALPNFIHLDYTLENPSIHFLTFTITM-------------EASDQFAFSGPKSLAVQ-LVPLSRHTVRYNL |
561 |
3 | -13.200 | PF00927.22; EPB42_HUMAN/588-686; Transglutaminase family, C-terminal ig like domain |
ali follow.. |
19 | 12 | .....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................EQYQPLTASVSLQNSLDAPMEDCVISILGRGLIHRERSYRFRSVWPENTMCAKFQFTPTHVGLQRLT........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
78 |
4 | -12.000 | PF06159.13; J3KCX7_COCIM/67-339; Protein of unknown function (DUF974 topsan) |
ali follow.. |
14 | 2 | ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MLPPAFGSAYVGETFSCSLSANNDASRVVTSIRILAEMQTPSQVVPLELYPSSDDND----------------------TKSGGIAQVESMQKIVR-LKEEGNHVLAVGVSYTETMITPSSDAHGSVQRTFRKLYQFVAQPCLNVR--------------------------------------------TKATELPPQEVDNRSLGPYGKTKLYRFALEAQLENVGDGIITLG-AVTLNPKPPFKSRSLNWDFESSADKESIPTLSPRDVLQIAFIVE------------------------QEHGQQDGLETLQKDMNREGRATLGQLSLEWR-SALGDRGFLTTGNL......................................................................................................................... |
271 |
5 | -11.900 | PF12739.7; E9PWG2_MOUSE/157-604; ER-Golgi trafficking TRAPP I complex 85 kDa subunit |
ali follow.. |
9 | 3 | ...............PM-----EQFSKLSQEQHRIQHNNDYSYPKWFIPNTLKY--------YVLLHDVTSGDEQRAESI--YEEMKQKYGLLKINSRAPNRKNSDSNLLSLDGLDNEVKVDGLPNNFRIHPLQIDQCGDPPNNTDGSESKSASSVHETKKASTAVIRGACLTLTDHDRIRQFIQEFT---FRGLLPHIEKTIRQLNDQ----------------------------------------------------------------------LISRKGLSRSLFSATKKWFSGSKVPEKSINELKNTSGLLYPPEAPELQIRKMADLCFLVQHYDLAYSCYHTAKKDFLNDQAMLYAAGALEMAAVSAFLQPGAPRP-------------------------------------------------YPAHYMDTAIQTYRDICKNM----------VLAERCVLLSAEILKSQSKYSEAAALLI---------------RLTSEDSDLRSALLLEQAAHCFINMKSPMVRKYAFHMILAG-FSKAGQKKHALRCYCQAMQVY.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
435 |
6 | -10.800 | PF12862.7; APC5_SCHPO/263-353; Anaphase-promoting complex subunit 5 |
ali follow.. |
14 | 28 | ..........................................................................................................................................................................................................................................................................................................................IMHSDEKVSYQYALLNLAMLQADFGCNEEALHAIEDTINTARESGDTACLNFALAWM................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ |
84 |
7 | -10.500 | PF14874.6; Q4DUQ4_TRYCC/1589-1690; Flagellar-associated PapD-like |
ali follow.. |
17 | 1 | ...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................VPTLSVMPSVLSFGRVIR--GNRYALPVVFTNTSTVPCR-YRVTLPTECKDILRVHYPRH--------------------------------FLAPGLTVMAQVEISGTQPLGAMSFSLNVTHEGGL------------IPVKVEIET............................................................................................................................................................................................................................................................................................................................................ |
101 |
8 | -10.300 | PF10633.9; Q67M97_SYMTH/263-339; NPCBM-associated, NEW3 domain of alpha-galactosidase |
ali follow.. |
16 | 4 | .......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................GRKNGVTLEVKNTGTTEITGINFASTLPP--------------------------------WTATFSPDSIDALAPGESRQVTVEVTPNSKALAGDYLVTLRARS................................................................................................................................................................................................................................................................................................................................................................... |
77 |
9 | -10.200 | PF15780.5; G3VKZ4_SARHA/34-131; Abnormal spindle-like microcephaly-assoc`d, ASPM-SPD-2-Hydin |
ali follow.. |
22 | 21 | ......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................VGVSRTLPLVLDNPNEEGVEVSVARLPAADKGFSISPQS-CALQSKERISLSITWTPAKEGRVR............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
83 |
10 | -10.000 | PF13424.6; Q4DK03_TRYCC/687-760; Tetratricopeptide repeat |
ali follow.. |
17 | 1 | ...................................................................................................................................................................................................................................................................................................................................HQRPLQNYAQLKCQLGDMLSALSLQETELEIAKEFGDTRATSRCMGAIALT............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
51 |
11 | -9.330 | PF12371.8; A9UVP6_MONBE/19-102; Transmembrane protein 131-like |
ali follow.. |
16 | 15 | ......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................LCKVAERVVTVVNG-NPRADLHLYSISSNSNDFHSSWFEHAVVAPGDNTTFTIAFMSETLGNITLLT.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... |
84 |
12 | -9.050 | PF06933.11; O44418_CHIPA/1-756; Special lobe-specific silk protein SSP160 |
ali follow.. |
6 | 2 | ........NIKVILVFFAQVAEGG----ISLLFSLFEVMVSVVFDVKSFT----SLSTPTCNSTVPSFATRVGGGRFS----------------TASFNMIAMISANVQAIQSGSGSTSGSSSSSTTSTSNSTTTTSNSTTTTTNSTTSSN----TSSGLTSSASVVSLIDTIAWVYQDSSVGIAYLMVSILALFYGQSVSAPPYPDLGIPALPANCSGPGVPQSVQIRAAIAYVNITIYFINMTGQQFEDLQGPVATDCGCPNTTSVAPLVLEWEAILAALQALANSTASANSTTSSNSTTTTTTNSTSTTTTNSTTTTNSTSSSNSSTIAGCIDISANFTIALQSLQALLLQESTCAPAL--SPCKPGKTASGCAKSGEKKVKRKARLEKMRAKCRRAVGNRMKGSMKKRVRSRAKKFGEAAKSGVRRYRKNIKYVYIPPVMASLNAYAALMASLSESISSQS.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. |
459 |
13 | -9.000 | PF05753.14; Q9VUZ0_DROME/9-186; Translocon-associated protein beta (TRAPB) |
ali follow.. |
12 | 10 | ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................CLSEDETRARLLVSKQILNKY---LVEKSDLLVRYTIFNVGSGAA--TKVRLVDSGFHPEAFDVVGGQPTAV---------------------------RIAPQTNFTHVLVVRGYFNFTAAEVSYKAVEESETLQLAVSS.......................................................................................................................................................................................................................................................................................................................................................... |
124 |